Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Endogenex™ Appoints Christopher Sorli as Chief Medical Officer 2023-05-18 22:00
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. 2023-05-18 21:23
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023 2023-05-18 20:25
Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility 2023-05-18 20:05
DISCOVERY LIFE SCIENCES JOINS AKOYA BIOSCIENCES' GLOBAL SERVICE PROVIDER NETWORK TO ACCELERATE IMMUNO-ONCOLOGY RESEARCH 2023-05-18 20:05
Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to exhibit at Medtec China 2023 2023-05-18 17:02
Malaysia Healthcare Travel Council Expands Global Reach 2023-05-18 14:28
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus 2023-05-18 14:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 11:53
Gleneagles Hospital Kuala Lumpur Applauded by Frost & Sullivan for Its Initiatives in Improving the Patient Experience and Customer Value 2023-05-18 10:13
Providence-based "Biotech start up" EpiVax Celebrates 25th Anniversary 2023-05-17 23:49
Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan 2023-05-17 21:13
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry 2023-05-17 18:00
Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases 2023-05-17 17:40
Inclusion of Recbio In the MSCI China Small Cap Index 2023-05-17 14:01
Antengene Announces NDA Submission for XPOVIO® in Indonesia 2023-05-17 08:30
Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density 2023-05-17 08:17
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings 2023-05-17 08:00
Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia 2023-05-17 07:48
DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS 2023-05-17 07:00
1 109 110 111 112 113 531